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Abstract: Oxygen is a commonly used drug in the clinical setting and like other drugs its 
use must be considered carefully. This is particularly true for those patients who are at risk 
of type II respiratory failure in whom the risk of hypercapnia is well established. In recent 
times, several international bodies have advocated for the prescription of oxygen therapy in 
an attempt to reduce this risk in vulnerable patient groups. Despite this guidance, published 
data have demonstrated that there has been poor uptake of these recommendations. Multiple 
interventions have been tested to improve concordance, and while some of these interventions 
show promise, the sustainability of these interventions are less convincing. In this review, we 
summarize data that have been published on the prevalence of oxygen prescription and the 
accurate and appropriate administration of this drug therapy. We also identify strategies that 
have shown promise in facilitating changes to oxygen prescription and delivery practice. There 
is a clear need to investigate the barriers, facilitators, and attitudes of clinicians in relation to the 
prescription of oxygen therapy in acute care. Interventions based on these findings then need 
to be designed and tested to facilitate the application of evidence-based guidelines to support 
sustained changes in practice, and ultimately improve patient care.
Keywords: chronic obstructive pulmonary disease, COPD, type II respiratory failure, oxygen 
therapy, prescribing, hypoxia, hypercapnia
Introduction
Oxygen is a commonly used drug in the clinical setting1–4 and unquestionably saves 
lives. However, its use must be carefully considered. Like any drug, it may cause 
harm when used inappropriately.4,5 In practice, a common misconception that “you 
can’t give too much oxygen”1,3 or “oxygen won’t hurt”4 has emerged. This has led to 
higher levels of oxygen therapy being delivered to patients who are critically unwell 
or who complain of dyspnea,3 resulting in increased lengths of stay,6 higher rates of 
admission to high dependency units,6 and an increased risk of death.7,8 Indeed, New9 
states that in the past ambulance crews regarded oxygen as a sort of “medical wet 
wipe […] not always therapeutic, but never harmful.”
The clinical effect supplemental oxygen can have on patients experiencing acute 
exacerbations of chronic obstructive pulmonary disease (COPD) is now widely 
known,10 yet not completely understood.11 Uncontrolled oxygen administration, 
particularly when delivered at high concentrations, can result in a worsening of 
hypercapnia.12,13 Multiple pathological mechanisms are believed to underlie this 
phenomenon,11,12,14,15 with the primary causes being the inhibition of pulmonary 
vasoconstriction. Resulting in a worse ventilation/perfusion mismatch, and a 
right-hand shift of the CO
2
 dissociation curve (Haldane effect), further increasing 
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a
CO
2
.13,16 Other mechanisms for this phenomenon include 
further increases in ventilation/perfusion mismatching due 
to absorption atelectasis and an increased work of breath-
ing due to the higher density of oxygen over air.17 Initial 
beliefs that hypercapnia was primarily caused as a result of 
a “reduced hypoxic drive” have been largely disproved,18 
following the publication of results challenging these earlier 
hypothesis. In 1980, Aubier et al18 demonstrated that while 
minute ventilation initially fell with the administration of 
high concentrations of oxygen therapy in the COPD patient 
cohort, this decrease was transient, with minute ventilation 
returning to levels only marginally lower than when breath-
ing room air initially.
For these reasons, the use of titrated oxygen therapy in 
this patient group has been advocated for many years. Guid-
ance from the British Thoracic Society (BTS),17 the Global 
Initiative for Obstructive Lung Disease19 and, more recently, 
the Thoracic Society of Australia and New Zealand20 advise 
clinicians to administer oxygen to maintain an SpO
2
 between 
88% and 92% in an acute hospital setting for patients with 
COPD and others who are vulnerable. While COPD is the 
most common chronic disease in clinical practice to cause 
hypercapnia,17 other vulnerable patient groups are also at 
risk. These include those patients with morbid obesity, 
obstructive sleep apnea, cystic fibrosis, neuromuscular 
disorders, those with restrictive chest wall deformities, and 
those using respiratory depressant drugs, such as opioids 
and benzodiazepines.17,21 In patients who are not at risk 
of hypercapnic respiratory failure, recommendations vary 
between professional bodies, with the BTS17,21 advocating 
for maintenance of an SpO
2 
between 94% and 98% and the 
Thoracic Society of Australia and New Zealand20 recom-
mending maintenance of an SpO
2
 between 92% and 96%. 
Undoubtedly, the accurate delivery of oxygen therapy is 
important for all patients; however, the deleterious effects 
of poor clinical practice in this area are most significant and 
now well documented in those patients who are vulnerable, 
particularly those with COPD.7,22–27 Austin et al7 were the 
first to show clear evidence of the benefits of administer-
ing titrated oxygen (delivered via nasal prongs to achieve 
an SpO
2 
between 88% and 92%) to patients with acute 
exacerbations of COPD. Their results demonstrated that 
the delivery of titrated oxygen therapy reduced mortality 
by 58% when compared with those who received high flow 
oxygen therapy (delivered via a nonrebreather mask at 
8–10 L/min).7 A retrospective review of ambulance practice, 
conducted by Cameron et al,28 illustrates this point. This study 
demonstrated that 80% of the patients with COPD brought 
in to the emergency department by ambulance had received 
high concentrations of oxygen during initial response and 
transfer. They reported an increased risk of serious adverse 
outcomes in patients who were both hypoxemic and hyper-
oxemic when compared to those who were normoxemic. 
However, hypercapnia and acidosis were more pronounced 
in the hyperoxemic group.
Many authors3,11,29–33 and professional bodies17,20 argue 
that oxygen should be treated like other drugs with orders 
for therapy included on a treatment (drug) chart to improve 
accurate administration. However, prescription of oxygen 
therapy has been historically poor, and compliance with or 
adherence to the written prescription has not been consis-
tently demonstrated. This review examines the literature 
that has explored prescribing practices internationally with 
a variety of interventions employed in attempts to improve 
prescription, administration, and consequently patient 
outcomes.
Oxygen prescription
The adequacy of oxygen prescription within the acute hos-
pital setting has been studied over many years.34–54 These 
studies have explored both the presence of a prescription 
and the adequacy and appropriateness of oxygen prescrip-
tion in a broad range of patient groups. The literature 
includes studies specific to vulnerable groups, including 
those with chronic ventilatory failure, but is not limited 
to this population with evaluation being undertaken in the 
general clinical setting. However, since the publication 
of the BTS Guidelines on acute oxygen administration in 
2008, there has been an increasing interest in this topic. 
Figure 1 depicts a timeline of papers (according to the 
geographical area that the studies were conducted) that 
have been published on oxygen therapy prescription and 
administration practices since 1980. Interestingly, over 27 
years, between 1980 and 2007, 17 papers33,35,41–44,46,47,49–51,53–58 
were found that discussed oxygen prescription rates and/
or the appropriateness and accuracy of oxygen administra-
tion and subsequent monitoring of oxygen therapy. In the 
6 years between 2009 and 2015, 12 papers which measured 
the accurate or appropriate prescription of oxygen therapy 
have been reported.34,36–40,45,48,52,59–61 Some of these papers 
also discussed various interventions that have been tested 
to improve prescription practices.
Overall, the literature suggests that the practice of pre-
scribing oxygen therapy is poor.34–39,41–44,46,47,49,51,52
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Figure 1 Timeline of papers published on oxygen therapy prescription and administration practices.
Notes: Between 1980 and 2007 (27 years), 17 papers were found. Between 2009 and 2015 (6 years), 12 papers were found. All papers published between 2009 and 2015 
measured the accurate or appropriate prescription of oxygen therapy ± various interventions to improve prescription rates.
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Various reasons have been proposed for this, including:
•	 insufficient training and education for medical and nurs-
ing staff;33,39,41,42,47,51,54,62
•	 a lack of familiarity with oxygen delivery devices;51
•	 a lack of understanding of the effects, role and dangers 
of oxygen therapy;35–37,46,61
•	 staff time constraints;48
•	 necessity to maintain SpO
2
 .94% due to the “between 
the flags” track and trigger observations charts;36
•	 practical issues related to space and place for prescribing 
oxygen;35,39,61
•	 difficulties with changing long established behavior;36,60
•	 patients transferred from other wards/departments with 
oxygen therapy already in situ;44
•	 lack of enthusiasm by senior clinical staff;44
•	 communication difficulties between doctors and nurses;36
•	 lack of full time staff or staff turnover.36,38,48,60
In attempts to improve overall prescription rates, differ-
ent interventions have been tested in various combinations 
over different periods of time, with varying degrees of 
success. Interventions that have been employed are pre-
sented in Table 1 and the degree of change achieved pre- and 
postintervention is presented graphically in Figure 2. These 
interventions include:
•	 introduction of oxygen alert stickers;39,59–61
•	 dedicated oxygen order chart;35
•	 clearly delineated section on the drug chart or changes 
to the drug chart to include space for the transcription of 
oxygen orders;34–36,48,60
•	 informational posters;59–61
•	 email notification/dissemination of information;60,61
•	 educational session across various clinical specialties and 
at various key times;34,36,39,44,48,56,59–61
•	 nurse facilitated reminder system;38
•	 development of hospital guidelines/policy to guide 
practice;36,42,59,60
•	 admission bundle with electronic prescribing system;45
•	 message alerts on computer login screens.60
One study42 demonstrated no or minimal improvement 
in prescribing practices after implementing an oxygen 
Table 1 Interventions that have been tested in attempts to improve oxygen prescription rates
Study (year) Intervention
Dodd et al35 (2000) 	 Dedicated oxygen order chart
	 Clearly delineated section on the drug chart or changes to the drug chart to include space for the transcription 
of oxygen orders
Akbar and Campbell42 (2006) 	 Introduction of hospital guidelines 
Hickey44 (2007) 	 educational sessions
Medford et al38 (2009) 	 Nurse facilitated reminder system
walters and Nadeem39 (2009) 	 Oxygen alert sticker
	 educational sessions
wijesinghe et al34 (2010) 	 Clearly delineated section on the drug chart or changes to the drug chart to include space for the transcription 
of oxygen orders
	 educational sessions
Khachi et al59 (2010) 	 Oxygen alert sticker
	 educational sessions
	 Informational posters
Nickless and Fallon60 (2011) 	 Development of hospital guidelines/policy to guide practice
	 educational sessions
	 Informational posters
	 Email notification/dissemination
	 Message alerts on computer login screen
	 Oxygen alert sticker
Young and Kostalas48 (2013) 	 Clearly delineated section on the drug chart or changes to the drug chart to include space for the transcription 
of oxygen orders
	 educational sessions
Gunathilake et al36 (2014) 	 Clearly delineated section on the drug chart or changes to the drug chart to include space for the transcription 
of oxygen orders
	 educational sessions
	 Development of hospital guidelines/policy to guide practice
Rudge et al61 (2014) 	 Oxygen alert sticker
	 Informational posters
	 Email notification/dissemination
	 educational sessions
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guideline to inform clinician practice. Despite no change 
in prescriber behavior, a large improvement was seen in the 
administration of oxygen according to the prescribed dose 
(70% vs 95%; P=0.043) and in the clinical assessment of all 
patients commenced on oxygen therapy, that is, increased 
measurement of pulse oximetry (69% vs 91%; P=0.001). 
The assessment of arterial blood gases for those with respi-
ratory disease improved following the introduction of the 
guideline (from 65% to 87%; statistical significance was 
not reported) with even greater improvements seen in the 
reevaluation of arterial blood gases following initiation of 
oxygen therapy for the cohort with airways disease, increas-
ing to 68% from 34% (P=0.037). The authors42 concluded 
that although little change was seen in the prescribing 
practices of the doctors, practice improvements were seen. 
Junior doctors reassessed arterial blood gases more fre-
quently and nurses administered the prescribed dose more 
frequently and used pulse oximetry more often to assess 
patients after the introduction of the guidelines.42 Similar 
improvements in administration and assessment have been 
seen in some practice areas in other studies34,38 but not in 
others47 in which the presence of an accurate prescription 
did not improve oxygen administration and assessment 
practices in these patients.
Rudge et al61 described a promising quality improvement 
project that occurred over three cycles which demonstrated 
dramatic improvements to the accurate prescription of 
oxygen therapy. Baseline data showed that 55% of patients 
using oxygen had a valid prescription; this then decreased to 
54% following cycle one, but improved to 94% at the end of 
cycle three. They used four interventions (oxygen prescrip-
tion chart, oxygen alert stickers, point of care resources, and 
senior led educational sessions) over a 2-year period on an 
Acute Medical Unit.61 While these data are encouraging, 
there are limitations with the study design; it was a quality 
improvement audit conducted in one unit of a single hospital 
and interventions were ongoing both prior to and during the 
data collection phase.
Similarly, in an earlier audit undertaken by Dodd et al,35 
a large improvement was seen in written prescription prac-
tice (before and after implementation of a specific oxygen 
prescription chart, from 55% to 91%; P=,0.001) with the 
accuracy of these written prescriptions improving signifi-
cantly (7% vs 77%; statistical significance was not reported) 
following the implementation of a dedicated chart on which 
oxygen therapy could be prescribed. The authors argued 
that junior doctors have inadequate levels of understanding 
about the effects and potential dangers of oxygen therapy; 
however, the improvements seen following the implemen-
tation of a dedicated oxygen prescription chart appear to 
indicate that junior doctors complete required documenta-
tion appropriately when it is available and the presence of 
a chart merely prompted this action. Importantly, this was 
a single-center study and no data in this study examined 
the adherence of other clinicians (nurses and other medical 
staff) to accurately deliver the actual prescription. However, 
the results from the study by Gunathilake et al36 suggest that 
appropriate oxygen delivery improved as prescription rates 
improved. They demonstrated that the number of patients at 
risk of type II respiratory failure with saturation levels above 
92% decreased from 47% at initial audit to 18% (P=0.04) 
following a multicomponent intervention and as prescrib-
ing rates increased (2.4% to 34%; P=,0.0001).36 Despite 
these encouraging results that demonstrate improvements 
in practice are possible, the sustainability of this behavior 
has been questioned by Young and Kostalas.48 They saw a 
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Figure 2 Accurate prescription of oxygen therapy: preintervention–postintervention study results.
Notes: Rates of improvement in prescribing for various interventions.
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significant improvement in prescription rates (from 12% 
to 74%; P=,0.001) 3 months following the introduction 
of an oxygen prescription section on the drug chart and the 
delivery of an educational session, but at 12 months this had 
decreased to 51%.
Also of interest is a study by Medford et al38 who 
implemented a nurse facilitated reminder system and found 
that there were relatively high rates of appropriate oxygen 
administration prior to the implementation of the reminder 
system, and that these did not change significantly on reaudit 
4 months after implementation (70.6% and 76.5%, respec-
tively; P=0.65). Here, nurses were empowered to remind 
doctors to prescribe oxygen therapy. This may indicate that in 
general, nurses are skilled at delivering the appropriate dose 
of oxygen despite the absence of a prescription as is indicated 
by the lack of practice change by the nurses and maintenance 
of a relatively high rate of appropriate administration of 
oxygen therapy both before and after the intervention.
Knowledge of oxygen therapy and 
delivery equipment
Knowledge of oxygen therapy and the equipment used to 
deliver oxygen may also be barriers to optimal oxygen admin-
istration. This has been highlighted in a study conducted by 
Ganeshan et al62 who reported that commonly used oxygen 
delivery devices, for example, nasal cannulae, are easily 
recognized by doctors and nurses with less frequently used 
devices, such as nonrebreathing masks, being poorly recog-
nized. In addition, when both medical and nursing clinicians 
were presented with sample case scenarios, a larger proportion 
(up 97% and 73% of doctors and nurses, respectively) were 
not able to accurately prescribe the correct dose of oxygen 
or the appropriate method for administration of oxygen for 
some of the scenarios described. Interestingly, this study62 
demonstrated that in four out of the seven case scenarios, 
nurses’ knowledge of the correct delivery devices and oxygen 
prescription was higher than that of the doctors. Overall, how-
ever, knowledge of correct prescriptions was suboptimal.
The authors argue that even if it were compulsory for 
medical staff to complete written prescriptions of oxygen 
therapy in wards settings, it is unlikely that staff would be 
able to prescribe it correctly. These findings are of particular 
concern in light of the current guideline recommendations.17,20 
Disturbingly, these are not stand alone results and are sup-
ported by findings from other studies63–65 that show there are 
large gaps in the knowledge of health care staff on various 
aspects of respiratory therapy. Considering the frequency 
with which oxygen is administered in an acute hospital setting 
and the harm that may be caused, interventions to improve 
the overall knowledge and practice around oxygen therapy 
and therefore concordance to evidence-based guidelines are 
urgently required.
Auditing practice
The BTS has conducted audits of prescribing practices within 
the National Health Service (NHS) since the implementation 
of the 2008 guidelines. These audits have demonstrated slow 
but steady improvements in the rates of oxygen prescrip-
tion. The most recently available data from the 2013 audit66 
demonstrated that 55% of patients who were using oxygen 
had some form of written order. This is an improvement 
from the 2008 audit which showed that only 32% of patients 
had a written order.66 These data also demonstrate a steady 
decline (17.5% down to 13.8%) in the number of patients 
within the NHS who are using oxygen therapy,66 which 
could result in improved patient outcomes and substantial 
savings for the health service. In contrast, an Australian audit 
demonstrated that as few as 3% of patients with COPD had 
an existing oxygen prescription despite 79% of patients with 
COPD receiving oxygen therapy at the time of audit.27 This 
improved level of practice in the UK, where regular audits 
are performed, may indicate that regular auditing and review 
of clinical practice and practice gaps can lead to improved 
clinician behavior.
Current recommendations and 
future directions
The NHS in their latest oxygen safety report67 suggests that 
the main safety concerns for oxygen administration relate 
to the under- and overuse of oxygen, and that these are caused 
by the inappropriate prescription, monitoring, and adminis-
tration of oxygen. Like the BTS, the NHS emphasizes the 
need for the accurate prescription and monitoring of patients 
with pulse oximetry. Similarly, the 2015 Thoracic Society of 
Australia and New Zealand guidelines for acute oxygen use 
in adults also recommend that oxygen therapy is prescribed 
with a specific record documented in the patient notes and 
drug chart, the main requirements being the documentation 
of a target SpO
2
 range.
It is clear that there is a need to improve the prescribing 
practices for all patients across hospital settings. Although 
the authors have postulated on the reasons behind why 
evidence-based guidelines are not adhered to, very little 
data exist examining why high flow oxygen continues to be 
given in practice (particularly in the prehospital and emer-
gency department setting) or why the written prescription of 
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oxygen therapy remains low. Medford et al38 and Hickey44 
suggest that analysis of doctors’ views on the prescription 
of oxygen therapy is needed and that strategies for optimiz-
ing the behavior of permanent nursing staff are necessary;38 
however, to date, few data have been published relating to 
these points. As such, little is known about the barriers or 
facilitators that exist to improve the implementation of these 
strategies in practice, yet, published literature from the past 
30 years demonstrates that despite a number of interventional 
strategies aimed at improving practice, it continues to be a 
challenging practice to change.
The knowledge practice gap is a common phenomenon in 
health care68 with some authors69 suggesting that the provision 
of guidelines and evidence from research, while necessary, 
are not sufficient in bridging the knowledge practice gap. 
Specifically, this has been demonstrated with the oxygen 
prescription data. A convincing evidence base now exists, 
yet the consistent application of the evidence (prescription 
and delivery of low flow oxygen to maintain SpO
2
 88%–92% 
in vulnerable patient groups) is not applied in daily practice. 
Funk et al70 argue that determining the perceptions of clini-
cians is vital in addressing this knowledge–practice gap. 
Ultimately, clinicians are responsible for the delivery of care. 
If we are to reduce or eliminate barriers to implementing 
research knowledge into practice, clinicians’ opinions are 
vital. Tailored interventions while effective can be variable; 
however, a 2015 Cochrane Review concluded that “interven-
tions tailored to address identified barriers are probably more 
likely to improve professional practice than no intervention 
or the dissemination of guidelines alone.”71
Conclusion
Throughout this review, we have presented international 
data surrounding current practice for the prescription of 
oxygen therapy. These data demonstrate that the rates of 
concordance to recommended practice have seen a neces-
sary change in oxygen prescription; however, there remains 
substantial room for improvement. This is evidenced in the 
large audit conducted by Roberts et al26 in 2010–2011 in 
which 16,018 patients admitted with acute exacerbations of 
COPD to hospitals in 13 European countries demonstrated 
a high level of adherence (85%) to the Global Initiative for 
Obstructive Lung Disease72 standards for the management of 
acute exacerbations of COPD, administering titrated oxygen 
therapy, to achieve PaO
2
 .60 mmHg or SpO
2
 .90%.72 
Despite this high level of adherence, .1,623 (10.1%) of 
the patients across the hospitals received either high flow 
oxygen or no supplemental oxygen (despite being hypoxic). 
Many practice gaps exist, which lead to poor patient 
outcomes. Pilcher and Beasley32 suggest that there is an 
entrenched culture of routine and indiscriminate adminis-
tration of high-concentration oxygen to acutely ill patients. 
This culture must change and there is a clear need to examine 
the barriers, facilitators, and attitudes toward oxygen and 
its prescription in acute care if we are to improve practice 
and minimize harm in vulnerable patient groups. Effective 
interventions may assist in translating expert guidelines 
into clinical practice. These may facilitate the adoption of 
best practice guidelines and ultimately improve clinical 
outcomes for COPD and other vulnerable patient groups 
who are most impacted by poor oxygen administration 
practices.
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